1. Home
  2. IMAB vs FVR Comparison

IMAB vs FVR Comparison

Compare IMAB & FVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • FVR
  • Stock Information
  • Founded
  • IMAB 2014
  • FVR 2016
  • Country
  • IMAB United States
  • FVR United States
  • Employees
  • IMAB N/A
  • FVR N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • FVR
  • Sector
  • IMAB Health Care
  • FVR
  • Exchange
  • IMAB Nasdaq
  • FVR NYSE
  • Market Cap
  • IMAB 200.9M
  • FVR 227.7M
  • IPO Year
  • IMAB 2020
  • FVR 2024
  • Fundamental
  • Price
  • IMAB $2.29
  • FVR $12.53
  • Analyst Decision
  • IMAB Strong Buy
  • FVR Hold
  • Analyst Count
  • IMAB 2
  • FVR 5
  • Target Price
  • IMAB $6.00
  • FVR $16.80
  • AVG Volume (30 Days)
  • IMAB 1.0M
  • FVR 358.5K
  • Earning Date
  • IMAB 05-15-2025
  • FVR 08-15-2025
  • Dividend Yield
  • IMAB N/A
  • FVR 6.86%
  • EPS Growth
  • IMAB N/A
  • FVR N/A
  • EPS
  • IMAB N/A
  • FVR N/A
  • Revenue
  • IMAB N/A
  • FVR $60,901,000.00
  • Revenue This Year
  • IMAB N/A
  • FVR $18.42
  • Revenue Next Year
  • IMAB N/A
  • FVR $6.26
  • P/E Ratio
  • IMAB N/A
  • FVR N/A
  • Revenue Growth
  • IMAB N/A
  • FVR 15.85
  • 52 Week Low
  • IMAB $0.60
  • FVR $10.61
  • 52 Week High
  • IMAB $3.08
  • FVR $19.76
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 53.66
  • FVR N/A
  • Support Level
  • IMAB $2.00
  • FVR N/A
  • Resistance Level
  • IMAB $2.95
  • FVR N/A
  • Average True Range (ATR)
  • IMAB 0.35
  • FVR 0.00
  • MACD
  • IMAB -0.07
  • FVR 0.00
  • Stochastic Oscillator
  • IMAB 30.53
  • FVR 0.00

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About FVR FRONTVIEW REIT INC

FrontView REIT Inc is an internally managed net-lease REIT that is experienced in acquiring, owning, and managing out parcel properties that are net-leased to a diversified group of tenants. The tenants of the company include service-oriented businesses, such as restaurants, cellular stores, financial institutions, automotive stores and dealers, medical and dental providers, pharmacies, convenience and gas stores, car washes, home improvement stores, grocery stores, professional services as well as general retail tenants.

Share on Social Networks: